Which Medications Trigger Prinzmetal Angina Spasms?
At a Glance
Triptans and ergot medicines, 5-FU and capecitabine chemotherapy, decongestants, some beta-blockers, cocaine, and nicotine can trigger Prinzmetal angina spasms. Review every medicine with a clinician, and seek emergency care for severe or unusual chest pain.
In this answer
5 sections
Certain medications can trigger Prinzmetal angina (coronary vasospasm) because their primary function or side effect is vasoconstriction—the narrowing of blood vessels. If you already have a tendency for your heart’s arteries to spasm, taking these drugs can provoke a severe and potentially dangerous episode. Important medication-related triggers include specific migraine medications (called triptans and ergot derivatives) and certain chemotherapy drugs used to treat cancer.
Always review every prescription, over-the-counter product, nasal spray, and supplement with your clinician or pharmacist before starting or stopping any treatment.
Emergency Warning
If you experience new, severe, persistent, or unusual chest pain, shortness of breath, fainting, marked sweating, or palpitations, call emergency services immediately. Do not drive yourself to the hospital. Follow your doctor’s instructions for using your prescribed nitroglycerin. A severe coronary spasm can lead to a true heart attack or dangerous heart rhythm [1][2]. Even if you suspect a medication caused the symptoms, you need urgent emergency evaluation [3].
Migraine Medications to Avoid
If you have Prinzmetal angina, you should not take a class of migraine medications known as triptans or ergot derivatives unless a specialist has thoroughly reviewed your case and explicitly approved their use [4][5]. Product labeling and clinical guidance generally consider vasospastic coronary disease a reason not to use these drugs (a contraindication).
Triptans work by stimulating specific receptors (called 5-HT1B receptors) that cause blood vessels in the brain to constrict, helping to stop a migraine attack [6]. However, these same receptors are in your heart’s coronary arteries. When activated, they can cause your heart’s arteries to narrow, triggering a spasm [6].
Specific triptans include:
- Sumatriptan [7][8]
- Rizatriptan [9]
- Zolmitriptan [8]
- Eletriptan [10]
- Naratriptan, Frovatriptan, and Almotriptan [9]
There have been reports of severe heart events, including heart attacks and dangerous heart rhythms, linked to sumatriptan and other triptans [7][11]. Similarly, ergot derivatives (such as ergotamine and dihydroergotamine) constrict blood vessels and pose similar cardiovascular risks [4][5]. Do not make unsupervised changes if you are currently taking these; contact your prescriber.
Non-vasoconstricting options to discuss:
Drugs like lasmiditan and a class known as gepants (such as ubrogepant and rimegepant) are not direct vasoconstrictors [12][13]. While they don’t cause triptan-like blood vessel narrowing, their cardiovascular safety data in patients with vasospastic disease is limited [12][13]. A neurologist or cardiologist must review your individual health history and potential drug interactions before prescribing them.
Cancer Medications That Can Trigger Spasms
Certain chemotherapy drugs, specifically a class called fluoropyrimidines, are well-established triggers for coronary vasospasm and broader heart toxicity (which can include heart attacks and arrhythmias) [14][15]. These include:
- 5-fluorouracil (5-FU): An intravenous chemotherapy [14][15].
- Capecitabine: An oral pill that works similarly [14][15].
Symptoms can happen within hours or days of starting the medication [3]. If you experience chest pain while taking these drugs, seek emergency care immediately and notify your oncology team. Do not simply stop the medication on your own without a doctor’s plan, but active infusions are generally stopped by the medical team while you are evaluated for acute coronary syndrome [3][16]. Any plan to restart treatment (a rechallenge) requires careful coordination between oncology and cardiology, often using medications like calcium-channel blockers or nitrates to relax blood vessels [16][17].
Rare case reports also suggest that nilotinib, a drug used for leukemia, may cause vasospasms, though it is more established as causing other arterial issues [18].
Other Important Medications to Discuss
- Beta-blockers: These are common heart medications, but some (particularly non-selective beta-blockers) can worsen coronary vasospasm in certain patients [19][20]. However, never stop a beta-blocker abruptly, as this can be dangerous. Discuss your medications with your cardiologist [20].
- Decongestants and Cold Medicines: Over-the-counter cold, allergy, and sinus medications often contain pseudoephedrine or phenylephrine. These are sympathomimetics that narrow blood vessels and can trigger spasms [21]. Always check the active ingredients of combination products.
- Epinephrine (Adrenaline) in Emergencies: Epinephrine can increase vasoconstriction [22]. However, you should NEVER delay or refuse life-saving epinephrine in an emergency, such as for a severe allergic reaction (anaphylaxis). Inform emergency personnel about your Prinzmetal angina, but accept the treatment [22].
- Recreational Drugs and Nicotine: Cocaine is a powerful vasoconstrictor and a well-known trigger for severe coronary spasms [23]. Cigarette smoking is strongly associated with triggering vasospastic angina [24]. If you are using nicotine replacement products to quit smoking, discuss this with your care team.
Quick Reference Guide
| Medication / Substance | Examples | Level of Concern | Patient Action |
|---|---|---|---|
| Triptans & Ergots | Sumatriptan, rizatriptan, ergotamine | High (Contraindicated) | Do not use unless a specialist explicitly directs you to. [4] |
| Fluoropyrimidines | 5-fluorouracil (5-FU), capecitabine | High | Discuss cardio-oncology monitoring. Seek emergency care if chest pain occurs. [3] |
| OTC Decongestants | Pseudoephedrine, phenylephrine | Moderate | Check active ingredients. Ask a pharmacist before use. [21] |
| Beta-blockers | Propranolol, metoprolol | Moderate | Discuss with your cardiologist. Never stop abruptly. [20] |
| Emergency Epinephrine | EpiPen, adrenaline | Emergency Use | Never delay in a life-threatening emergency. Inform EMTs of your condition. [22] |
Common questions in this guide
Which migraine medications can trigger Prinzmetal angina?
Can 5-FU or capecitabine cause coronary spasms?
Which over-the-counter cold medicines should I avoid?
Can beta-blockers worsen Prinzmetal angina?
Are lasmiditan or gepants safe if I have Prinzmetal angina?
Should I avoid epinephrine because I have Prinzmetal angina?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Get notified when new evidence is published on Prinzmetal angina.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my Prinzmetal angina, what non-vasoconstricting options exist for managing my severe migraines?
- 2.If I need chemotherapy with 5-fluorouracil or capecitabine, how will my cardiology and oncology teams coordinate to monitor my heart and plan alternatives?
- 3.Are there specific over-the-counter cold, allergy, or sinus ingredients I should completely avoid, and what are safe alternatives?
- 4.Should I carry a medical-alert card listing my diagnosis, prescribed rescue medicines, and contraindicated medications?
- 5.Are any of my current daily medications, such as beta-blockers, potentially worsening my spasms?
References
References (24)
- 1
Vasospastic angina: a review on diagnostic approach and management.
Jenkins K, Pompei G, Ganzorig N, et al.
Therapeutic advances in cardiovascular disease 2024; (18()):17539447241230400 doi:10.1177/17539447241230400.
PMID: 38343041 - 2
Spontaneous Multivessel Coronary Spasm During Diagnostic Coronary Angiography.
Damera RR, Ijlal Khan M, Oliynyk V, Javaid A
Texas Heart Institute journal 2022; (49(2)) doi:10.14503/THIJ-20-7357.
PMID: 35377456 - 3
Vasospastic Angina Following Capecitabine Initiation: A Rare But Serious Cardiotoxic Effect.
Ponce Simal S, Martínez Fleta M, Prados Arnedo M, et al.
The Journal of emergency medicine 2026; (82()):94-98 doi:10.1016/j.jemermed.2025.12.027.
PMID: 41687429 - 4
The 5-HT1B and 5-HT1D agonists in acute migraine therapy: Ergotamine, dihydroergotamine, and the triptans.
Whealy M, Becker WJ
Handbook of clinical neurology 2024; (199()):17-42 doi:10.1016/B978-0-12-823357-3.00008-2.
PMID: 38307644 - 5
Migraine.
Ferrari MD, Goadsby PJ, Burstein R, et al.
Nature reviews. Disease primers 2022; (8(1)):2 doi:10.1038/s41572-021-00328-4.
PMID: 35027572 - 6
Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy?
Rubio-Beltrán E, Labastida-Ramírez A, Villalón CM, MaassenVanDenBrink A
Pharmacology & therapeutics 2018; (186()):88-97 doi:10.1016/j.pharmthera.2018.01.005.
PMID: 29352859 - 7
Fatal coronary vasospasm following oral triptan intake.
Djellal IY, Mansour S, Berdaoui B, et al.
Journal of cardiology cases 2025; (31(6)):170-173 doi:10.1016/j.jccase.2025.02.007.
PMID: 40519697 - 8
Cardiovascular adverse events associated with triptans for treatment of migraine: a pharmacovigilance study of the FDA adverse event reporting system (FAERS).
Sharma P, Varghese Gupta S, Bhatt P, et al.
Canadian journal of physiology and pharmacology 2024; (102(12)):720-728 doi:10.1139/cjpp-2024-0117.
PMID: 39435747 - 9
Targeting the 5-HT1B/1D and 5-HT1F receptors for acute migraine treatment.
Huang PC, Yang FC, Chang CM, Yang CP
Progress in brain research 2020; (255()):99-121 doi:10.1016/bs.pbr.2020.05.010.
PMID: 33008517 - 10
Eletriptan-Associated Coronary Vasospasm in a Heart Transplant Recipient.
Yong Y, Teng LE, Velusamy R, et al.
JACC. Case reports 2026; 109808 doi:10.1016/j.jaccas.2026.109808.
PMID: 42610998 - 11
A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.
Xu N, Lu X
Journal of pain research 2025; (18()):5331-5345 doi:10.2147/JPR.S551333.
PMID: 41103977 - 12
Characterization of binding, functional activity, and contractile responses of the selective 5-HT1F receptor agonist lasmiditan.
Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, et al.
British journal of pharmacology 2019; (176(24)):4681-4695 doi:10.1111/bph.14832.
PMID: 31418454 - 13
Integrating gepants into clinical practice for the acute treatment of migraine.
Lipton RB, Dodick DW, Davis L, et al.
Headache 2026; (66(4)):976-989 doi:10.1111/head.70047.
PMID: 41709494 - 14
The Incidence, Risk Factors, and Outcomes With 5-Fluorouracil-Associated Coronary Vasospasm.
Zafar A, Drobni ZD, Mosarla R, et al.
JACC. CardioOncology 2021; (3(1)):101-109 doi:10.1016/j.jaccao.2020.12.005.
PMID: 33817666 - 15
Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A, Vaage-Nilsen M, Schou M, et al.
Acta oncologica (Stockholm, Sweden) 2020; (59(4)):475-483 doi:10.1080/0284186X.2019.1711164.
PMID: 31931649 - 16
5-Fluorouracil-Induced Microvascular Vasospasm Diagnosed by Coronary Functional Testing.
Rana R, Wallace RL, Waksman R, et al.
JACC. Case reports 2025; (30(27)):105137 doi:10.1016/j.jaccas.2025.105137.
PMID: 40940119 - 17
The Role of Vasospasm and Microcirculatory Dysfunction in Fluoropyrimidine-Induced Ischemic Heart Disease.
Fabin N, Bergami M, Cenko E, et al.
Journal of clinical medicine 2022; (11(5)) doi:10.3390/jcm11051244.
PMID: 35268333 - 18
Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib.
Maruta S, Usami K, Tajiri K, et al.
Cardio-oncology (London, England) 2021; (7(1)):31 doi:10.1186/s40959-021-00119-6.
PMID: 34452646 - 19
Pharmacotherapy of Vasospastic Angina.
Harris JR, Hale GM, Dasari TW, Schwier NC
Journal of cardiovascular pharmacology and therapeutics 2016; (21(5)):439-51 doi:10.1177/1074248416640161.
PMID: 27081186 - 20
Comparison of nebivolol versus diltiazem in improving coronary artery spasm and quality of life in patients with hypertension and vasospastic angina: A prospective, randomized, double-blind pilot study.
Kook H, Hong SJ, Yang KS, et al.
PloS one 2020; (15(9)):e0239039 doi:10.1371/journal.pone.0239039.
PMID: 32915892 - 21
Acute Myocardial Infarction from Coronary Vasospasm Precipitated by Pseudoephedrine and Metoprolol Use.
Meoli EM, Goldsweig AM, Malm BJ
The Canadian journal of cardiology 2017; (33(5)):688.e1-688.e3 doi:10.1016/j.cjca.2017.01.005.
PMID: 28347584 - 22
Tacrolimus-Induced Diffuse Coronary Artery Spasm.
Samer A, Almehmadi F, Krimly A, Alrajhi A
Cureus 2022; (14(6)):e25748 doi:10.7759/cureus.25748.
PMID: 35812568 - 23
Cocaine-induced pseudo-Wellens' syndrome: a Wellens' phenocopy.
Lin AN, Lin S, Gokhroo R, Misra D
BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-222835.
PMID: 29246935 - 24
The Smoking Paradox: A Twist in the Tale of Vasospastic Angina.
Tran MV, Marceau E, Lee PY, et al.
Journal of vascular medicine & surgery 2021; (9(7)).
PMID: 36276915
This page explains medication and substance triggers for Prinzmetal angina for informational purposes only and does not constitute medical advice. Have a cardiologist or pharmacist review your medicines before you start, stop, or change them.